Conversion from cognitive health to mild cognitive impairment and Alzheimer's disease: Prediction by plasma amyloid beta 42, medial temporal lobe atrophy and homocysteine
To access this article, please choose from the options below
PII: S0197-4580(06)00334-4
doi:10.1016/j.neurobiolaging.2006.09.002
© 2006 Elsevier Inc. All rights reserved.
